Immune Netw.
2019 Jun;19(3):e18. 10.4110/in.2019.19.e18.
Respiratory Syncytial Virus Fusion Protein-encoding DNA Vaccine Is Less Effective in Conferring Protection against Inflammatory Disease than a Virus-like Particle Platform
- Affiliations
-
- 1Center for Inflammation, Immunity & Infection, Institute for Biomedical Sciences, Georgia State University, Atlanta, GA 30303, USA. skang24@gsu.edu
- 2Department of Microbiology, Chonnam National University Medical School, Hwasun 58128, Korea.
- 3Green Cross Cell Corp., Yongin 16924, Korea.
- 4Komipharm Co., Ltd., Siheung 15094, Korea.
- 5Animal and Plant Quarantine Agency, Gimcheon 39660, Korea.
- 6Department of Medical Zoology, Kyung Hee University School of Medicine, Seoul 02447, Korea.
- 7Meissa Vaccines, South San Francisco, CA 94080, USA.
- KMID: 2450203
- DOI: http://doi.org/10.4110/in.2019.19.e18
Abstract
- Formalin-inactivated respiratory syncytial virus (RSV) vaccination causes vaccine-enhanced disease (VED) after RSV infection. It is considered that vaccine platforms enabling endogenous synthesis of RSV immunogens would induce favorable immune responses than non-replicating subunit vaccines in avoiding VED. Here, we investigated the immunogenicity, protection, and disease in mice after vaccination with RSV fusion protein (F) encoding plasmid DNA (F-DNA) or virus-like particles presenting RSV F (F-VLP). F-DNA vaccination induced CD8 T cells and RSV neutralizing Abs, whereas F-VLP elicited higher levels of IgG2a isotype and neutralizing Abs, and germinal center B cells, contributing to protection by controlling lung viral loads after RSV challenge. However, mice that were immunized with F-DNA displayed weight loss and pulmonary histopathology, and induced F specific CD8 T cell responses and recruitment of monocytes and plasmacytoid dendritic cells into the lungs. These innate immune parameters, RSV disease, and pulmonary histopathology were lower in mice that were immunized with F-VLP after challenge. This study provides important insight into developing effective and safe RSV vaccines.
Keyword
MeSH Terms
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Need for a safe vaccine against respiratory syncytial virus infection
- In Hot Pursuit of the First Vaccine Against Respiratory Syncytial Virus
- Immunogenicity and Protective Efficacy of a Dual Subunit Vaccine Against Respiratory Syncytial Virus and Influenza Virus
- Porcine reproductive and respiratory syndrome virus vaccine does not fit in classical vaccinology
- Recovery of respiratory syncytial virus, adenovirus, influenza virus , and parainfluenza virus from nasopharyngeal aspirates from children with acute respiratory tract infections
